Skip to content

A Study of LY3200882 in Participants With Solid Tumors.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507177-17-00
Acronym
I8X-MC-JECA
Enrollment
1
Registered
2024-02-27
Start date
2016-11-21
Completion date
Unknown
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic cancer, Solid Tumor

Interventions

None listed

Sponsors

Eli Lilly & Co.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026